 | • レポートコード：MRC2Q12-19095 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、成長ホルモンニードルのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 成長ホルモンニードルのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 成長ホルモンニードルの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 成長ホルモンニードルのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの成長ホルモンニードルの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の成長ホルモンニードルの売上および2028年までの予測に焦点を当てています。 成長ホルモンニードルのグローバル主要企業には、Norditropin、Novo Nordisk、Ferring Holding SA、Eli Lilly and Company、Genentech, Inc.、GeneScience Pharmaceuticals Co., Ltd.、Merck KgaA、Pfizer, Inc.、Sandoz International GmbHなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 成長ホルモンニードル市場は、タイプとアプリケーションによって区分されます。世界の成長ホルモンニードル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 パウダーインジェクション、ワッサーインジェクション 【アプリケーション別セグメント】 大人用、子供用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 成長ホルモンニードル製品概要 - タイプ別市場（パウダーインジェクション、ワッサーインジェクション） - アプリケーション別市場（大人用、子供用） - 調査の目的 ・エグゼクティブサマリー - 世界の成長ホルモンニードル販売量予測2017-2028 - 世界の成長ホルモンニードル売上予測2017-2028 - 成長ホルモンニードルの地域別販売量 - 成長ホルモンニードルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別成長ホルモンニードル販売量 - 主要メーカー別成長ホルモンニードル売上 - 主要メーカー別成長ホルモンニードル価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（パウダーインジェクション、ワッサーインジェクション） - 成長ホルモンニードルのタイプ別販売量 - 成長ホルモンニードルのタイプ別売上 - 成長ホルモンニードルのタイプ別価格 ・アプリケーション別市場規模（大人用、子供用） - 成長ホルモンニードルのアプリケーション別販売量 - 成長ホルモンニードルのアプリケーション別売上 - 成長ホルモンニードルのアプリケーション別価格 ・北米市場 - 北米の成長ホルモンニードル市場規模（タイプ別、アプリケーション別） - 主要国別の成長ホルモンニードル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの成長ホルモンニードル市場規模（タイプ別、アプリケーション別） - 主要国別の成長ホルモンニードル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の成長ホルモンニードル市場規模（タイプ別、アプリケーション別） - 主要国別の成長ホルモンニードル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の成長ホルモンニードル市場規模（タイプ別、アプリケーション別） - 主要国別の成長ホルモンニードル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの成長ホルモンニードル市場規模（タイプ別、アプリケーション別） - 主要国別の成長ホルモンニードル市場規模（トルコ、サウジアラビア） ・企業情報 Norditropin、Novo Nordisk、Ferring Holding SA、Eli Lilly and Company、Genentech, Inc.、GeneScience Pharmaceuticals Co., Ltd.、Merck KgaA、Pfizer, Inc.、Sandoz International GmbH ・産業チェーン及び販売チャネル分析 - 成長ホルモンニードルの産業チェーン分析 - 成長ホルモンニードルの原材料 - 成長ホルモンニードルの生産プロセス - 成長ホルモンニードルの販売及びマーケティング - 成長ホルモンニードルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 成長ホルモンニードルの産業動向 - 成長ホルモンニードルのマーケットドライバー - 成長ホルモンニードルの課題 - 成長ホルモンニードルの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Growth Hormone Needle is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Growth Hormone Needle is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Growth Hormone Needle is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Growth Hormone Needle include Norditropin, Novo Nordisk, Ferring Holding SA, Eli Lilly and Company, Genentech, Inc., GeneScience Pharmaceuticals Co., Ltd., Merck KgaA, Pfizer, Inc. and Sandoz International GmbH, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Growth Hormone Needle manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Growth Hormone Needle market. Further, it explains the major drivers and regional dynamics of the global Growth Hormone Needle market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Norditropin
Novo Nordisk
Ferring Holding SA
Eli Lilly and Company
Genentech, Inc.
GeneScience Pharmaceuticals Co., Ltd.
Merck KgaA
Pfizer, Inc.
Sandoz International GmbH
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Growth Hormone Needle Segment by Type
Powder Injection
Wasser Injection
Growth Hormone Needle Segment by Application
Aldult
Child
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Growth Hormone Needle market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Growth Hormone Needle, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Growth Hormone Needle, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Growth Hormone Needle, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Growth Hormone Needle sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Growth Hormone Needle market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Growth Hormone Needle sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Norditropin, Novo Nordisk, Ferring Holding SA, Eli Lilly and Company, Genentech, Inc., GeneScience Pharmaceuticals Co., Ltd., Merck KgaA, Pfizer, Inc. and Sandoz International GmbH, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Growth Hormone Needle in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Growth Hormone Needle manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Growth Hormone Needle sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Growth Hormone Needle Product Introduction
1.2 Market by Type
1.2.1 Global Growth Hormone Needle Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Powder Injection
1.2.3 Wasser Injection
1.3 Market by Application
1.3.1 Global Growth Hormone Needle Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Aldult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Growth Hormone Needle Sales Estimates and Forecasts 2017-2028
2.2 Global Growth Hormone Needle Revenue Estimates and Forecasts 2017-2028
2.3 Global Growth Hormone Needle Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Growth Hormone Needle Sales by Region
2.4.1 Global Growth Hormone Needle Sales by Region (2017-2022)
2.4.2 Global Sales Growth Hormone Needle by Region (2023-2028)
2.5 Global Growth Hormone Needle Revenue by Region
2.5.1 Global Growth Hormone Needle Revenue by Region (2017-2022)
2.5.2 Global Growth Hormone Needle Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Growth Hormone Needle Sales by Manufacturers
3.1.1 Global Top Growth Hormone Needle Manufacturers by Sales (2017-2022)
3.1.2 Global Growth Hormone Needle Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Growth Hormone Needle in 2021
3.2 Global Growth Hormone Needle Revenue by Manufacturers
3.2.1 Global Growth Hormone Needle Revenue by Manufacturers (2017-2022)
3.2.2 Global Growth Hormone Needle Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Growth Hormone Needle Revenue in 2021
3.3 Global Growth Hormone Needle Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Growth Hormone Needle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Growth Hormone Needle Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Growth Hormone Needle Sales by Type
4.1.1 Global Growth Hormone Needle Historical Sales by Type (2017-2022)
4.1.2 Global Growth Hormone Needle Forecasted Sales by Type (2023-2028)
4.1.3 Global Growth Hormone Needle Sales Market Share by Type (2017-2028)
4.2 Global Growth Hormone Needle Revenue by Type
4.2.1 Global Growth Hormone Needle Historical Revenue by Type (2017-2022)
4.2.2 Global Growth Hormone Needle Forecasted Revenue by Type (2023-2028)
4.2.3 Global Growth Hormone Needle Revenue Market Share by Type (2017-2028)
4.3 Global Growth Hormone Needle Price by Type
4.3.1 Global Growth Hormone Needle Price by Type (2017-2022)
4.3.2 Global Growth Hormone Needle Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Growth Hormone Needle Sales by Application
5.1.1 Global Growth Hormone Needle Historical Sales by Application (2017-2022)
5.1.2 Global Growth Hormone Needle Forecasted Sales by Application (2023-2028)
5.1.3 Global Growth Hormone Needle Sales Market Share by Application (2017-2028)
5.2 Global Growth Hormone Needle Revenue by Application
5.2.1 Global Growth Hormone Needle Historical Revenue by Application (2017-2022)
5.2.2 Global Growth Hormone Needle Forecasted Revenue by Application (2023-2028)
5.2.3 Global Growth Hormone Needle Revenue Market Share by Application (2017-2028)
5.3 Global Growth Hormone Needle Price by Application
5.3.1 Global Growth Hormone Needle Price by Application (2017-2022)
5.3.2 Global Growth Hormone Needle Price Forecast by Application (2023-2028)
6 North America
6.1 North America Growth Hormone Needle Market Size by Type
6.1.1 North America Growth Hormone Needle Sales by Type (2017-2028)
6.1.2 North America Growth Hormone Needle Revenue by Type (2017-2028)
6.2 North America Growth Hormone Needle Market Size by Application
6.2.1 North America Growth Hormone Needle Sales by Application (2017-2028)
6.2.2 North America Growth Hormone Needle Revenue by Application (2017-2028)
6.3 North America Growth Hormone Needle Market Size by Country
6.3.1 North America Growth Hormone Needle Sales by Country (2017-2028)
6.3.2 North America Growth Hormone Needle Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Growth Hormone Needle Market Size by Type
7.1.1 Europe Growth Hormone Needle Sales by Type (2017-2028)
7.1.2 Europe Growth Hormone Needle Revenue by Type (2017-2028)
7.2 Europe Growth Hormone Needle Market Size by Application
7.2.1 Europe Growth Hormone Needle Sales by Application (2017-2028)
7.2.2 Europe Growth Hormone Needle Revenue by Application (2017-2028)
7.3 Europe Growth Hormone Needle Market Size by Country
7.3.1 Europe Growth Hormone Needle Sales by Country (2017-2028)
7.3.2 Europe Growth Hormone Needle Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Growth Hormone Needle Market Size by Type
8.1.1 Asia Pacific Growth Hormone Needle Sales by Type (2017-2028)
8.1.2 Asia Pacific Growth Hormone Needle Revenue by Type (2017-2028)
8.2 Asia Pacific Growth Hormone Needle Market Size by Application
8.2.1 Asia Pacific Growth Hormone Needle Sales by Application (2017-2028)
8.2.2 Asia Pacific Growth Hormone Needle Revenue by Application (2017-2028)
8.3 Asia Pacific Growth Hormone Needle Market Size by Region
8.3.1 Asia Pacific Growth Hormone Needle Sales by Region (2017-2028)
8.3.2 Asia Pacific Growth Hormone Needle Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Growth Hormone Needle Market Size by Type
9.1.1 Latin America Growth Hormone Needle Sales by Type (2017-2028)
9.1.2 Latin America Growth Hormone Needle Revenue by Type (2017-2028)
9.2 Latin America Growth Hormone Needle Market Size by Application
9.2.1 Latin America Growth Hormone Needle Sales by Application (2017-2028)
9.2.2 Latin America Growth Hormone Needle Revenue by Application (2017-2028)
9.3 Latin America Growth Hormone Needle Market Size by Country
9.3.1 Latin America Growth Hormone Needle Sales by Country (2017-2028)
9.3.2 Latin America Growth Hormone Needle Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Growth Hormone Needle Market Size by Type
10.1.1 Middle East and Africa Growth Hormone Needle Sales by Type (2017-2028)
10.1.2 Middle East and Africa Growth Hormone Needle Revenue by Type (2017-2028)
10.2 Middle East and Africa Growth Hormone Needle Market Size by Application
10.2.1 Middle East and Africa Growth Hormone Needle Sales by Application (2017-2028)
10.2.2 Middle East and Africa Growth Hormone Needle Revenue by Application (2017-2028)
10.3 Middle East and Africa Growth Hormone Needle Market Size by Country
10.3.1 Middle East and Africa Growth Hormone Needle Sales by Country (2017-2028)
10.3.2 Middle East and Africa Growth Hormone Needle Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Norditropin
11.1.1 Norditropin Corporation Information
11.1.2 Norditropin Overview
11.1.3 Norditropin Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Norditropin Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Norditropin Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Overview
11.2.3 Novo Nordisk Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novo Nordisk Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novo Nordisk Recent Developments
11.3 Ferring Holding SA
11.3.1 Ferring Holding SA Corporation Information
11.3.2 Ferring Holding SA Overview
11.3.3 Ferring Holding SA Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Ferring Holding SA Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ferring Holding SA Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 Genentech, Inc.
11.5.1 Genentech, Inc. Corporation Information
11.5.2 Genentech, Inc. Overview
11.5.3 Genentech, Inc. Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Genentech, Inc. Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Genentech, Inc. Recent Developments
11.6 GeneScience Pharmaceuticals Co., Ltd.
11.6.1 GeneScience Pharmaceuticals Co., Ltd. Corporation Information
11.6.2 GeneScience Pharmaceuticals Co., Ltd. Overview
11.6.3 GeneScience Pharmaceuticals Co., Ltd. Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GeneScience Pharmaceuticals Co., Ltd. Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GeneScience Pharmaceuticals Co., Ltd. Recent Developments
11.7 Merck KgaA
11.7.1 Merck KgaA Corporation Information
11.7.2 Merck KgaA Overview
11.7.3 Merck KgaA Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck KgaA Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck KgaA Recent Developments
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Corporation Information
11.8.2 Pfizer, Inc. Overview
11.8.3 Pfizer, Inc. Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer, Inc. Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer, Inc. Recent Developments
11.9 Sandoz International GmbH
11.9.1 Sandoz International GmbH Corporation Information
11.9.2 Sandoz International GmbH Overview
11.9.3 Sandoz International GmbH Growth Hormone Needle Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sandoz International GmbH Growth Hormone Needle Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sandoz International GmbH Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Growth Hormone Needle Industry Chain Analysis
12.2 Growth Hormone Needle Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Growth Hormone Needle Production Mode & Process
12.4 Growth Hormone Needle Sales and Marketing
12.4.1 Growth Hormone Needle Sales Channels
12.4.2 Growth Hormone Needle Distributors
12.5 Growth Hormone Needle Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Growth Hormone Needle Industry Trends
13.2 Growth Hormone Needle Market Drivers
13.3 Growth Hormone Needle Market Challenges
13.4 Growth Hormone Needle Market Restraints
14 Key Findings in The Global Growth Hormone Needle Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer